Lauren P. Carboni
Senior Counsel
Lauren Carboni is a health care focused attorney who counsels clients across the industry on complex regulatory, compliance, litigation, and enforcement matters. Lauren represents a broad range of organizations in the health care and life sciences sector, which includes health systems, hospitals, physician groups, durable medical equipment suppliers and distributors, and others. With a litigation background and as a regulatory advisor, Lauren offers clients strategic counsel on fraud and abuse issues, regulatory risk management, internal investigations, and defense against government inquiries. She co-chairs the Health Care & Life Sciences Sector鈥檚 Health Care Litigation Area of Focus and has extensive experience with False Claims Act litigation, audits, internal investigations, risk assessments, providing health care regulatory due diligence advice on transactions, and administrative appeals involving federal and state enforcement agencies.
In addition to her robust health care practice, Lauren advises clients in the cannabis and psychedelic sectors on regulatory compliance, licensing, and business operations, with a focus on navigating the intersection of state and federal law. Her multidisciplinary perspective helps clients across highly regulated sectors address emerging risks and seize new opportunities.
Lauren is committed to providing pro bono services. She strives to represent clients in the Colorado community to ensure every person and organization, regardless of financial means, has access to the justice system. Notable pro bono successes include advocating to the parole board for the release of a disabled client from prison to obtain much-needed health care, and obtaining a settlement with a municipal police department that compensated a disabled client for injuries sustained during a traffic stop.
Awards and Recognition
- Colorado Super Lawyers庐鈥 Rising Stars lists (2017鈥2020, 2022-2025), which recognizes the top 2.5 percent of Colorado lawyers under 40 years of age
- 5280鈥檚 Denver鈥檚 Top Lawyers (2022, 2025, 2026)
- Trial Lawyer of the Year Finalist (2017), Public Justice, for representation of an incarcerated individual challenging his conditions of confinement and access to medical care
Affiliations
- Member, American Health Lawyers Association
- Member, Colorado Bar Association, Health Law Section
- Member, Colorado Women鈥檚 Bar Association
- Member, Psychedelic Bar Association; Co-Steward of the Legislation and Regulation Committee
- Former Member, Chanda Center for Health Board
Publications and Presentations
- Presenter, “Chanda Center for Health: Reimagining Access to and Delivery of Long-term Disability Care,” Health Care Law Today Podcast (January 5, 2026)
- Co-author, “,” Law360 (January 2, 2026)
- Co-author, “,” American Bar Association (December 17, 2025)
- Co-author, “How Following 鈥淒octors鈥 Orders鈥 Provided a Defense in a First Circuit FCA Case,” Health Care Law Today (December 9, 2025)
- Co-author, “HHS Guidance Excluding Non-Qualified Aliens from More Federal Programs Raises Questions for Providers and Grantees,” Health Care Law Today (July 29, 2025)
- Author, “Colorado Medicaid: RAC Program Overhauled with Enhanced Transparency, Greater Provider Protections, and Increased Oversight,” Health Care Law Today (July 15, 2025)
- Author, 鈥New Mexico Becomes Third State in the U.S. to Legalize Access to Psilocybin,鈥 Health Care Law Today (April 9, 2025)
- Co-author, 鈥Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access and Medicare Coverage,鈥 Health Care Law Today (July 29, 2024)
- Co-author, 鈥FDA Continues to Take Stance That it Will Not Issue CBD Rules,鈥 Health Care Law Today (April 24, 2024)
- Co-author, 鈥2023 Going Digital Health鈥檚 Behavioral Health Tech Conference: Key Investment Takeaways,鈥 Health Care Law Today (November 27, 2023)
- Co-author, 鈥Psychedelic Drugs 鈥 Easing the Regulatory Hurdles for Development,鈥澛Health Care Law Today聽(December 15, 2022)
- Co-author, 鈥,鈥澛Association of Corporate聽Counsel聽(December 6, 2022)
- Author, 鈥Colorado Legalizes Therapeutic Psychedelics 鈥 Now What?,鈥澛Health Care Law Today聽(November 14, 2022)
- Author, 鈥The Psychedelics Renaissance is Here – Colorado May Become the Second State in the Nation to Legalize Therapeutic Psychedelics,鈥澛Health Care Law Today聽(October 26, 2022)
- Co-author, 鈥What To Know About the New Colorado False Claims Act,鈥澛Health Care Law Today聽(June 28, 2022)
- Co-author, “Cannabis Mid-Year Update 2022,” 麻豆传媒 & Lardner Webinar (June 6, 2022)
- Co-author, “Behavioral Health Trends for 2022,” 麻豆传媒 & Lardner Webinar (March 31, 2022)
- Co-author, 鈥Compliance Issues in Hospital and Health System Sports Sponsorships,鈥 Health Care Law Today (February 9, 2022)
- Co-author, 鈥A Target on Telehealth: Government Action Against Telehealth Fraud in the Wake of COVID-19,鈥 American Health Law Association (July 14, 2021)
- Co-author, 鈥Latest Open Payments Data Released Under Heightened Government Scrutiny,鈥 Health Care Law Today (July 9, 2021)
- Co-author, 鈥The New Face of COVID-19 Fraud Enforcement: An Inter-Agency Task Force,鈥 Coronavirus Resource Center: Back to Business (May 21, 2020)
- Co-author, 鈥The City of Denver a Trendsetter in Cannabis Reform?,鈥澛Legal News: Cannabis Industry (April 26, 2021)
- Presenter, 鈥淚mplications of a Repealed ACA,鈥 Colorado State of Reform 2020 Teleconference (November 17, 2020)
- Co-author, 鈥Government Seizure of Medical Supplies from Health Care Providers 鈥 Is It Legal?,鈥澛Coronavirus Resource Center: Back to Business (May 15, 2020)
- Presenter, 鈥淐OVID-19 Provider Relief Funding Webinar,鈥 麻豆传媒 & Lardner Webinar (April 27, 2020)
- Co-author, 鈥COVID-19: Understanding HHS鈥檚 Plans to Disperse Provider Relief Funds Authorized By The CARES Act,鈥 Coronavirus Resource Center: Back to Business (April 27, 2020)
- Co-author, 鈥COVID-19 Not Slowing Efforts to Update Denver鈥檚 Cannabis Rule,鈥 Coronavirus Resource Center: Back to Business (April 21, 2020)
- Co-author, 鈥COVID-19: 鈥淗ospitals Without Walls鈥 and 鈥淧atients Over Paperwork鈥 – Key Takeaways For Hospitals From CMS鈥 Additional Blanket Waivers,鈥 Coronavirus Resource Center: Back to Business (April 6, 2020)
- Co-author, 鈥COVID-19: Washington Becomes the Second State Approved for 1135 Medicaid Waiver 鈥 Key Takeaways,鈥 Coronavirus Resource Center: Back to Business (March 23, 2020)
- Author, 鈥淧rime Healthcare Services and its CEO Agree to Pay $65 Million to Settle Fraud Claims: The Government Sends A Clear Message That It Takes Unnecessary Inpatient Stays and ‘Upcoding’ Seriously,鈥 Journal of Health Care Compliance (November-December 2018)
- Co-author, 鈥淲ork Product Immunity,鈥 Discovery in Colorado (2017, 2018)
- Presenter, 鈥,鈥 Colorado Bar Association CLE (June 21, 2017)
- Co-author, 鈥淢anaging Risks When Working with Experts and Consultants,鈥 The Colorado Lawyer (June 2017)
- Co-author, 鈥淎ttorney-Witnesses Face a Host of Hazards,鈥 The Colorado Lawyer (November 18, 2016)
- Co-author, 鈥淣ew Approach To Pleading Standards From Colo. High Court,鈥 Law360 (August 26, 2016)
- Author, 鈥,鈥 American Bar Association (May 24, 2016)
DOJ Fraud Section Launches West Coast Strike Force to Target Health Care Fraud in Arizona, California, Nevada, and Other Western States
On April 30, 2026, the Department of Justice鈥檚 National Fraud Enforcement Division announced the launch of a new West Coast Strike Force, a multi-district enforcement initiative joining the Division鈥檚 Health Care Fraud Section with U.S. Attorney鈥檚 Offices for the Districts of Arizona, Nevada, and Northern California.
Psychedelics and the Executive Order: From Schedule I to Treatment Priority
The Order represents a significant federal policy shift aimed at addressing what the Trump Administration describes as a crisis of serious mental illness in America.
Marijuana - Some Products Reclassified to Schedule III: What It Means, What It Doesn鈥檛, and What Comes Next
On April 23, 2026, the U.S. Department of Justice and Drug Enforcement Administration (DEA) announced a long-awaited final order (Final Order) placing certain categories of marijuana and marijuana products into Schedule III of the Controlled Substances Act (CSA), in accordance with President Trump鈥檚 December 18, 2025, Executive Order on Increasing Medical Marijuana and Cannabidiol Research.
Hemp Product Use in Medicare: CMS Greenlights Pilot Program under the Substance Access Beneficiary Engagement Incentive
On April 1, 2026, the Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center (CMMI), officially launched a new pilot program which allows participants in specific CMS programs to offer eligible hemp products to eligible Medicare beneficiaries.
Litigation Risks: Protecting Telemedicine/Digital Health Companies
麻豆传媒's聽Health Care Litigation and聽Telemedicine & Digital Health聽Areas of Focus are hosting a three-part webinar series covering the most pressing litigation trends impacting the telemedicine and digital health industry.
/Passle/67196104ea6deed3d1072b7a/MediaLibrary/Images/2025-05-20-14-23-19-395-682c9057975255c097204ded.jpg)
Immigrant Access to Health Centers: Confronting Unknowns in the Administration鈥檚 Revised Interpretation of PRWORA
This article was originally published in the ABA鈥檚 Health Law Section, December 2025, and is reposted here with permission.聽 In July...